Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

NCT02126020 is registered in ClinicalTrials.gov with James Chodosh, MD, MPH as lead sponsor.

NCT NCT02126020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02126020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Lead sponsor
James Chodosh, MD, MPH
Phase
Phase 1/2
Overall status
Withdrawn
Start date
November 30, 2014
Completion date
April 3, 2017
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mucous membrane pemphigoid, stevens-johnson syndrome, toxic epidermal necrolysis (lyell) syndrome